- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Distribution of top public funders for R&D on neglected diseases 2017
Distribution of top public funders for R&D on neglected diseases 2017
Percentage of top countries in public funding for research and development on neglected diseases in 2017*
by John Elflein,
last edited
Feb 4, 2019
This statistic shows the percentage of the top public funders for research and development on neglected diseases worldwide in 2017. In that year, the United States was responsible for some 69 percent of the total global funding for R&D on neglected diseases.
Percentage of top countries in public funding for research and development on neglected diseases in 2017*
Loading statistic...
Expand statistic
| Percentage of total funding | |
|---|---|
| United States | 69% |
| United Kingdom | 8% |
| European Union | 5.2% |
| India | 3.3% |
| Germany | 2.8% |
| France | 2% |
| Netherlands | 1% |
| Australia | 1% |
| Switzerland | 0.8% |
| Japan | 0.8% |
| South Africa | 0.6% |
| Canada | 0.6% |
| Percentage of total funding | |
|---|---|
| United States | 69% |
| United Kingdom | 8% |
| European Union | 5.2% |
| India | 3.3% |
| Germany | 2.8% |
| France | 2% |
| Netherlands | 1% |
| Australia | 1% |
| Switzerland | 0.8% |
| Japan | 0.8% |
| South Africa | 0.6% |
| Canada | 0.6% |
© Statista 2019
About this statistic
Source: Policy Cures
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by John Elflein,
last edited
Feb 4, 2019
This statistic shows the percentage of the top public funders for research and development on neglected diseases worldwide in 2017. In that year, the United States was responsible for some 69 percent of the total global funding for R&D on neglected diseases.
- Source
- Policy Cures
- Show further sources information
- Show publisher information
- Release date
- January 2019
- Region
- Worldwide
- Survey time period
- 2017
- Supplementary notes
- * Neglected Diseases are mostly tropical infectious diseases that receive less attention behind the big diseases (usually: HIV, malaria, tuberculosis) and are therefore labeled 'neglected'.
- Open this statistic in...
Source
- Source
- Policy Cures
- Show further sources information
- Show publisher information
- Release date
- January 2019
More information
- Region
- Worldwide
- Survey time period
- 2017
- Supplementary notes
- * Neglected Diseases are mostly tropical infectious diseases that receive less attention behind the big diseases (usually: HIV, malaria, tuberculosis) and are therefore labeled 'neglected'.
- Open this statistic in...
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Diseases
- 97 page/s
- English
- pptx
- Detailed references
Everything On "Diseases" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Diseases"
- Global disease deaths
The most important statistics
- Leading causes of death worldwide in 2016 (in millions)Global death rate - leading causes 2016
- Leading 10 causes of death in low-income countries worldwide in 2016 (in deaths per 100,000 population)Top ten causes of deaths in low-income countries 2016
- Leading 10 causes of death in upper income countries in 2016 (in deaths per 100,000 population)Top ten causes of deaths in upper income countries 2016
- Number of deaths caused by selected chronic diseases worldwide as of 2016 (in 1,000)Deaths caused by chronic diseases 2016
- Number of deaths caused by selected communicable diseases annually worldwide as of 2016 (in 1,000)Annual deaths number from communicable diseases 2016
- Leading 20 countries based on probability of mortality due to non-communicable diseases between ages 30 to 70 in 2016Countries with highest probable mortality due to non-communicable diseases 2016
- U.S. disease deaths
The most important statistics
- Top 10 causes of death in the U.S. in 1900 and 2017 (per 100,000 population)Major causes of death in the U.S.: 1900 and 2017
- Distribution of the 10 leading causes of death in the United States in 2017Leading causes of death in the United States 2017
- Percentage changes in selected causes of death in the U.S. between 2000 and 2017, by diseasePercentage changes in selected causes of death in the U.S. 2000-2017
- Parkinson's disease death rate in the U.S. from 1999 to 2017 (per 100,000 population)Death rate from Parkinson's disease U.S. 1999-2017
- Cancer
The most important statistics
- Number of cancer deaths worldwide in 2018, by major type of cancerCancer deaths worldwide by major type 2018
- Deaths by cancer in the U.S. from 1950 to 2016 (per 100,000 population)*Deaths by cancer in the U.S. 1950-2016
- Number of U.S. Americans with a history of cancer living between 2004 and 2019 (in millions)U.S. Americans with a history of cancer living 2004-2019
- Availability of new cancer drugs launched in 2013-2017 in selected countries as of 2018Availability of new cancer drugs by country as of 2018
- Heart diseases
The most important statistics
- Deaths from ischemic heart disease in OECD countries in 2015 (per 100,000 population)Ischemic heart disease - deaths in selected countries 2015
- Heart disease risk in the U.S. between 2000 and 2016, by age*Heart disease risk by age in the U.S. 2000-2016
- Deaths by heart diseases in the U.S. from 1950 to 2016 (per 100,000 population)Deaths by heart diseases in the U.S. 1950-2016
- Diabetes
The most important statistics
- Estimated number of diabetics worldwide in 2017 and 2045 (in millions)Diabetics worldwide 2017 and 2045
- Number of U.S. Americans with diagnosed diabetes from 1980 to 2015 (in millions)*Number of U.S. Americans with diabetes 1980-2015
- Deaths by diabetes mellitus in the U.S. from 1950 to 2016 (per 100,000 population)Deaths by diabetes mellitus in the U.S. 1950-2016
- Leading U.S. states based on percentage of adults who ever had diabetes as of 2017*Percentage of U.S. adults with diabetes, by top U.S. states 2017
- Alzheimer/dementia
The most important statistics
- Projected numbers of older people with Alzheimer’s in the U.S. from 2010 to 2050 (in millions)*Projected numbers of older people with Alzheimer's in the U.S. 2010-2050
- Projected number of people aged 65 and over with Alzheimer's disease in the U.S. in 2019 and 2025, by state (in thousands)Total number of Alzheimer's disease elderly patients U.S. by state 2019 and 2025
- Distribution of Alzheimer's disease patients in the United States as of 2019, by age groupShare of patients with Alzheimer's disease in the U.S. by age group 2019
- Neglected tropical diseases
The most important statistics
- Leading 20 countries based on number of people needing interventions against neglected tropical diseases (NTDs) in 2016Countries with largest number of people requiring action against NTDs worldwide 2016
- Number of countries affected worldwide from select neglected tropical diseases as of 2019Number of countries affected by neglected tropical diseases worldwide as of 2019
- Number of people affected worldwide each year from select neglected tropical diseases as of 2019 (in millions)Number of people affected by select neglected tropical diseases worldwide as of 2019
- Number of cases of Guinea worm disease worldwide from 1986 to 2018Cases of Guinea worm disease worldwide from 1986 to 2018
- Number of reported and expected cases of human African trypanosomiasis worldwide from 2008 to 2020Reported and expected cases of human African trypanosomiasis worldwide 2008-2020
- Selected notifiable diseases - U.S.
The most important statistics
- Number of new cases of hepatitis A and B in the U.S. from 1970 to 2016New cases of hepatitis in the U.S. 1970-2016
- Number of new cases of Lyme disease in the U.S. from 1991 to 2016*New cases of Lyme disease in the U.S. 1991-2016
- Number of new cases of meningococcal disease in the U.S. from 1970 to 2016New cases of meningococcal disease in the U.S. 1970-2016
- Number of new cases of measles (rubeola) in the U.S. from 1950 to 2019New cases of measles in the U.S. 1950-2019
- Number of new cases of syphilis in the U.S. from 1950 to 2016*New cases of syphilis in the U.S. 1950-2016
- Number of new cases of tuberculosis in the U.S. from 1960 to 2016*Number of new cases of tuberculosis in the U.S. 1960-2016
- Number of malaria cases in the U.S. from 2001 to 2016Malaria cases in the U.S. 2001-2016
- Research and development
The most important statistics
- Donated funds for research and development by disease in 2017 (in million U.S. dollars)*Research and development funding for diseases worldwide 2017
- Distribution of total global funding on research and development for selected diseases from 2013 to 2017Distribution of total funding on R&D for selected diseases 2013-2017
- Top countries in public funding for research and development on neglected diseases in 2017 (in million U.S. dollars)Top public funders for R&D on neglected diseases by country 2017
- Percentage of top countries in public funding for research and development on neglected diseases in 2017*Distribution of top public funders for R&D on neglected diseases 2017
- Top philanthropic funders for research and development on neglected diseases worldwide in 2017 (in million U.S. dollars)Leading philanthropic funders for research and development on neglected diseases 2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Diseases: Top R & D funds among philanthropic foundations 2017
- Share of global at-risk population for malaria protected by IRS as of 2017, by region
- Immunization coverage for children at 24 months in Canada 2015 and 2017, by antigen
- U.S. government support for late-stage neglected disease pipeline candidates 2015
- Total U.S. disease investment 2008-2017 by disease
- Worldwide therapeutic licensing and acquisition deals share 2009-2018 by disease type
- U.S. venture funding of therapeutic companies by disease type 2018
- Research and Development: charity donations for diseases 2007
- Chronic diseases: patients' responsibility
- U.S. disease investment by share of disease and investment type 2009-2018
- Public funding for movies in Denmark 2009-2019
- Ireland: Sport Ireland high performance sport investments in IABA 2013-2019
- Avoidable antibiotics outpatient prescriptions in the U.S. by disease 2012
- Athletes funded by UK Sport in the United Kingdom 2016-2019, by age group
- Syringe service programs for drug users in U.S. by public funding 2013
- Italy: CAP policy funding in wine green harvesting 2009-2018
- Contribution to public funding by the mobile industry in Europe in 2016
- Haiti: distribution of funding to international organizations 2014-2016
- Costa Rica: funding to international organizations 2014-2016, by type
- Colombia: annual funding to international organizations 2014-2016, by type
Topics
Studies
- Pharmaceutical research and development
- G-Finder - Neglected Disease Research and Development 2018
- Clinical trials
- G-Finder - Neglected Disease Research and Development 2017
- Biotechnology Industry in Europe
- Orphan drugs
- Drug use in the Nordic countries
- G-Finder - Neglected Disease Research and Development 2013
- G-Finder - Neglected Disease Research and Development 2015
- G-Finder - Neglected Disease Research and Development 2014
- G-Finder - Neglected Disease Research and Development 2012
- G-Finder - Neglected Disease Research and Development 2016
- Measuring the return of pharmaceutical innovation 2018
- Doing our part: Innovating to fight Neglected Tropical Diseases (2017)
- Pharma R&D Annual Review 2019
Statistics on "Diseases"
- Global death rate - leading causes 2016
- Top ten causes of deaths in low-income countries 2016
- Top ten causes of deaths in upper income countries 2016
- Deaths caused by chronic diseases 2016
- Annual deaths number from communicable diseases 2016
- Countries with highest probable mortality due to non-communicable diseases 2016
- Major causes of death in the U.S.: 1900 and 2017
- Leading causes of death in the United States 2017
- Percentage changes in selected causes of death in the U.S. 2000-2017
- Death rate from Parkinson's disease U.S. 1999-2017
- Cancer deaths worldwide by major type 2018
- Deaths by cancer in the U.S. 1950-2016
- U.S. Americans with a history of cancer living 2004-2019
- Availability of new cancer drugs by country as of 2018
- Ischemic heart disease - deaths in selected countries 2015
- Heart disease risk by age in the U.S. 2000-2016
- Deaths by heart diseases in the U.S. 1950-2016
- Diabetics worldwide 2017 and 2045
- Number of U.S. Americans with diabetes 1980-2015
- Deaths by diabetes mellitus in the U.S. 1950-2016
- Percentage of U.S. adults with diabetes, by top U.S. states 2017
- Projected numbers of older people with Alzheimer's in the U.S. 2010-2050
- Total number of Alzheimer's disease elderly patients U.S. by state 2019 and 2025
- Share of patients with Alzheimer's disease in the U.S. by age group 2019
- Countries with largest number of people requiring action against NTDs worldwide 2016
- Number of countries affected by neglected tropical diseases worldwide as of 2019
- Number of people affected by select neglected tropical diseases worldwide as of 2019
- Cases of Guinea worm disease worldwide from 1986 to 2018
- Reported and expected cases of human African trypanosomiasis worldwide 2008-2020
- New cases of hepatitis in the U.S. 1970-2016
- New cases of Lyme disease in the U.S. 1991-2016
- New cases of meningococcal disease in the U.S. 1970-2016
- New cases of measles in the U.S. 1950-2019
- New cases of syphilis in the U.S. 1950-2016
- Number of new cases of tuberculosis in the U.S. 1960-2016
- Malaria cases in the U.S. 2001-2016
- Research and development funding for diseases worldwide 2017
- Distribution of total funding on R&D for selected diseases 2013-2017
- Top public funders for R&D on neglected diseases by country 2017
- Distribution of top public funders for R&D on neglected diseases 2017
- Leading philanthropic funders for research and development on neglected diseases 2017
- Diseases: Top R & D funds among philanthropic foundations 2017
- Share of global at-risk population for malaria protected by IRS as of 2017, by region
- Immunization coverage for children at 24 months in Canada 2015 and 2017, by antigen
- U.S. government support for late-stage neglected disease pipeline candidates 2015
- Total U.S. disease investment 2008-2017 by disease
- Worldwide therapeutic licensing and acquisition deals share 2009-2018 by disease type
- U.S. venture funding of therapeutic companies by disease type 2018
- Research and Development: charity donations for diseases 2007
- Chronic diseases: patients' responsibility
- U.S. disease investment by share of disease and investment type 2009-2018
- Public funding for movies in Denmark 2009-2019
- Ireland: Sport Ireland high performance sport investments in IABA 2013-2019
- Avoidable antibiotics outpatient prescriptions in the U.S. by disease 2012
- Athletes funded by UK Sport in the United Kingdom 2016-2019, by age group
- Syringe service programs for drug users in U.S. by public funding 2013
- Italy: CAP policy funding in wine green harvesting 2009-2018
- Contribution to public funding by the mobile industry in Europe in 2016
- Haiti: distribution of funding to international organizations 2014-2016
- Costa Rica: funding to international organizations 2014-2016, by type
- Colombia: annual funding to international organizations 2014-2016, by type
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month*
| |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Yes, let me download!
...and make my research life easier.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.